The role of the catechol-O-methyltransferase (COMT) gene in cognitive function has been the subject of some debate. The gene, which affects dopamine, comes in two flavors: Val and Met. One recent study found no difference between healthy carriers of these two gene variants in terms of cognitive performance, but did find differences in terms of neural activity. Another found that, although the gene did not affect Alzheimer’s risk in its own, it acted synergistically with the Alzheimer’s gene variant to do so. Now an eight-year study of nearly 3000 adults in their 70s has revealed that the Met variant of the COMT gene was linked to a greater decline in cognitive function. This effect was more pronounced for African-Americans. This is interesting because it has been the Val genotype that in other research has been shown to have a detrimental effect. It seems likely that this genotype must be considered in its context (age, race, gender, and ApoE status have all been implicated in research).
Gene variant may protect memory and thinking skills in older people
Related News
Brain fitness program produces working memory improvement in older adults
While brain training programs can certainly improve your ability to do the task you’re practicing, there has been little evidence that this transfers to other tasks. In particular, the holy grail has been very broad transfer, through improvement in working memory. While there has been some evidence of this in pilot programs for children with ADHD, a new study is the first to show such improvement in older adults using a commercial brain training program.
Low vitamin D levels associated with cognitive decline
Another study has come out showing that older adults with low levels of vitamin D are more likely to have cognitive problems. The six-year study followed 858 adults who were age 65 or older at the beginning of the study. Those who were severely deficient in vitamin D were 60% more likely to have substantial cognitive decline, and 31% more likely to have specific declines in executive function, although there was no association with attention.
Common medications increase risk of mild cognitive impairment
Anticholinergics are widely used for a variety of common medical conditions including insomnia, allergies, or incontinence, and many are sold over the counter. Now a large six-year study of older African-Americans has found that taking one anticholinergic significantly increased an individual's risk of developing mild cognitive impairment and taking two of these drugs doubled this risk. The risk was greater for those who didn’t have the ‘Alzheimer’s gene’, APOE-e4.
Brain training reverses age-related cognitive decline
A rat study demonstrates how specialized brain training can reverse many aspects of normal age-related cognitive decline in targeted areas. The month-long study involved daily hour-long sessions of intense auditory training targeted at the primary auditory cortex. The rats were rewarded for picking out the oddball note in a rapid sequence of six notes (five of them of the same pitch). The difference between the oddball note and the others became progressively smaller. After the training, aged rats showed substantial reversal of their previously degraded ability to process sound.
Obesity and body shape linked to poorer brain function in older women
A very large study of older women has found that although there was a small downward trend in cognitive function (as measured by the MMSE) with increasing obesity, this trend was almost entirely driven by those with a waist-hip ratio below 0.78 — that is, for women who carry excess weight around their hips, known as pear shapes (as opposed to carrying it around the waist, called apple shapes).
Benefits of music training on the brain
A review of the many recent studies into the effects of music training on the nervous system strongly suggests that the neural connections made during musical training also prime the brain for other aspects of human communication, including learning. It’s suggested that actively engaging with musical sounds not only helps the plasticity of the brain, but also helps provide a stable scaffolding of meaningful patterns. Playing an instrument primes the brain to choose what is relevant in a complex situation.
Promise of drug therapy for age-related memory loss
Although research has so far been confined to mouse studies, researchers are optimistic about the promise of histone deacetylase inhibitors in reversing age-related memory loss — both normal decline, and the far more dramatic loss produced by Alzheimer’s. The latest study reveals that memory impairment in the aging mouse is associated with altered hippocampal chromatin plasticity, specifically with the failure of histone H4 lysine 12 acetylation, leading to a failure to initiate the gene expression program associated with memory consolidation.
One cause of cognitive decline with age
A rhesus monkey study has revealed which dendritic spines are lost with age, providing a new target for therapies to help prevent age-association cognitive impairment. It appears that it is the thin, dynamic spines in the dorsolateral prefrontal cortex, which are key to learning new things, establishing rules, and planning, that are lost. Learning of a new task was correlated with both synapse density and average spine size, but was most strongly predicted by the head volume of thin spines.
Extending lifespan has mixed effects on learning and memory
Studies on the roundworm C. elegans have revealed that the molecules required for learning and memory are the same from C. elegans to mammals, suggesting that the basic mechanisms underlying learning and memory are ancient, and that this animal can serve as a testing ground for treatments for age-related memory loss. Intriguingly, a comparison of two known regulators of longevity — reducing calorie intake and reducing activity in the insulin-signaling pathway (achieved through genetic manipulation) — has found that these two treatments produce very different effects on memory.
Cognitive ability, not age, predicts risky decisions
A study involving 54 older adults (66-76) and 58 younger adults (18-35) challenges the idea that age itself causes people to become more risk-averse and to make poorer decisions. Analysis revealed that it is individual differences in processing speed and memory that affect decision quality, not age. The stereotype has arisen no doubt because more older people process slowly and have poorer memory.
Pagination
- Previous page ‹‹
- Page 13
- Next page ››